Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases - Cross-sectional study

Croatian Medical Journal

Volumn 50, Issue 2, 2009, Pages 124-132

  Kanižaj, Tajana Filipec ^a   Katičić, Miroslava ^a   Presečki, Vladimir ^b   Gašparov, Slavko ^a   Cvrlje, Vesna Colić ^a   Kolarić, Branko ^c   Mrzljak, Anna ^a  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Zagreb County Institute of Public Health   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CAGA PROTEIN; FLAGELLIN; OUTER MEMBRANE PROTEIN; PROTEIN P120; PROTEIN P17; PROTEIN P19; PROTEIN P26; PROTEIN P29; PROTEIN P30; PROTEIN P33; PROTEIN P54; PROTEIN P57; PROTEIN P66; PROTEIN P67; PROTEIN P95; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DUODENUM ULCER; DYSPEPSIA; FEMALE; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; PEPTIC ULCER; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH MUCOSA; STOMACH ULCER; WESTERN BLOTTING; AGE DISTRIBUTION; AGED; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DUODENUM TUMOR; GASTROINTESTINAL TUMOR; HELICOBACTER INFECTION; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOGENICITY; PATHOLOGY; PROGNOSIS; RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX RATIO; STOMACH TUMOR;

ADULT; AGE DISTRIBUTION; AGED; ANTIGENS, BACTERIAL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DUODENAL NEOPLASMS; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIC ULCER; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STOMACH NEOPLASMS;

EID: 67651070883     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.124     Document Type: Article

References (42)

1. Blaser MJ. Science, medicine, and future: Helicobacter pylori and gastric diseases. BMJ. 1998; 316: 1507-10. Medline:9582144
2. Strnad M, Presecki V, Babus V, Turek S, Dominis M, Kalenic S, et al. Epidemiology of Helicobacter pylori infection [Article in Polishin Croatian]. Lijec Vjesn. 2002; 124 Suppl 1: 5-9. Medline:12592807
3. Kolk H. Evaluation of symptom presentation in dyspeptic patients referred for upper gastrointestinal endoscopy in Estonia. Croat Med J. 2004; 45: 592-8. Medline:15495287
4. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest. 1997; 100: 759-62. Medline:9259572 doi:10.1172/JCi119588
5. Jakic-Razumovic J, Tentor D, Kusec V, Cuzic S, Brkic T. Histopathological features of gastritis before and after treatment for Helicobacter pylori. Croat Med J. 2000; 41: 159-62. Medline:10853044
6. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer. 2000; 88: 274-9. Medline:10640957 doi:10.1002/(SICI) 1097-0142 (20000115) 88:2<274::Aid-CNCR5>3.0. CO;2-9
7. Enroth H, Kraaz W, Engstrand L, Nyren O, Rohan T. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2000; 9: 981-5. Medline:11008919
8. Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, et al. Assessment of gastric carcinoma risk associated with helicobacter pylori may vary depending on the antigen used: CagA specifc enzyme-linked immunoadsorbent assay (eliSA) versus commercially available h. pylori eliSAs. Cancer. 2000; 88: 1530-5. Medline:10738209 doi:10.1002/(SiCi) 1097-0142 (20000401) 88:7<1530::AID-CNCR5>3.0. CO;2-4
9. Pan ZJ, van der hulst RW, Tytgat GN, Dankert J, van der Ende A. Relation between vacA subtypes, cytotoxin activity, and disease in helicobacter pylori-infected patients from The Netherlands. Am J Gastroenterol. 1999; 94: 1517-21. Medline:10364017 doi:10.1111/j.1572-0241.1999.01136.x (Pubitemid 29260438)
10. van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WG. Distinct variants of helicobacter pylori cag A are associated with vac A subtypes. J Clin Microbiol. 1999; 37: 2306-11. Medline:10364602
11. Sadakane Y, Kusaba K, Nagasawa Z, Tanabe I, Kuroki S, Tadano J. Prevalence and genetic diversity of cagD, cagE, and vacA in Helicobacter pylori strains isolated from Japanese patients. Scand J Gastroenterol. 1999; 34: 981-6. Medline:10563667 doi:10.1080/0036 55299750025075
12. Slater E, Owen RJ, Williams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and iS605 diversity. Gastroenterology. 1999; 117: 1308-15. Medline:10579972 doi:10.1016/S0016-5085 (99) 70281-7
13. van Doorn NE, Namavar F, van Doorn LJ, Durrani Z, Kuipers EJ, Vandenbroucke-Grauls CM. Analysis of vacA, cagA, and IS605 genotypes and those determined by PCR amplification of dNA between repetitive sequences of Helicobacter pylori strains isolated from patients with nonulcer dyspepsia or mucosa-associated lymphoid tissue lymphoma. J Clin Microbiol. 1999; 37: 2348-9. Medline:10364612
14. Domingo D, Alarcon T, Prieto N, Sanchez I, lopez-Brea M. cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol. 1999; 37: 2113-4. Medline:10383258
15. Telford JI, Ghiara P, Dell'orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J exp Med. 1994; 179: 1653-8. Medline:8163943 doi:10.1084/jem.179.5.1653
16. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55: 2111-5. Medline:7743510
17. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kda immunodominant antigen of helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993; 90: 5791-5. Medline:8516329 doi:10.1073/pnas.90.12.5791
18. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, et al. Serologic detection of infection with cagA+ helicobacter pylori strains. J Clin Microbiol. 1995; 33: 1496-500. Medline:7650174
19. Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol. 1994; 47: 227-31. Medline:8163693 doi:10.1136/jcp. 47.3.227
20. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov I. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defned by eliSA and immunoblotting. Int J Cancer. 1996; 67: 1-5. Medline:8690507 doi:10.1002/(SiCi) 1097-0215 (19960703) 67:1<1::Aid-iJC1>3.0. Co;2-0
21. Bazillou M, Fendri C, Castel O, Ingrand P, Fauchere JL. Serum antibody response to the superfcial and released components of helicobacter pylori. Clin Diagn Lab immunol. 1994; 1: 310-7. Medline:7496968
22. Mitchell HM, Hazell SL, Kolesnikow T, Mitchell J, Frommer D. Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect immun. 1996; 64: 1166-72. Medline:8606074
23. Schumann C, Triantafilou K, Rasche FM, Moricke A, Vogt K, Triantafilou M, et al. Serum antibody positivity for distinct helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol. 2006; 296: 223-8. Medline:16600680 doi:10.1016/j.ijmm.2006.02.009 (Pubitemid 44016169)
24. Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol. 1998; 36: 931-6. Medline:9542911
25. The World Medical Association. declaration of helsinki. Available from: www.wma.net/e/ethicsunit/helsinki.htm. Accessed: April 9, 2009.
26. Dixon MF, Genta RM, Yardley Jh, Correa P. Classifcation and grading of gastritis. The updated Sydney System. International Workshop on the histopathology of Gastritis, houston 1994. Am J Surg Pathol. 1996; 20: 1161-81.
27. Kuipers EJ, Schenk BE, Meuwissen SG. Helicobacter pylori: who is positive and who is not? Eur J Gastroenterol Hepatol. 1995; 7: 533-6. Medline:7552635
28. Lofeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ. Functional dyspepsia is associated with cagA-positive helicobacter pylori strains. Scand J Gastroenterol. 2001; 36: 351-5. Medline:11336157 doi:10.1080/003655201300051072
29. Vorobjova T, Maaroos HI, Uibo R. Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus. APMiS. 2008; 116: 465-76. Medline:18754320 doi:10.1111/j.1600-0463.2008. 00934.x
30. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001; 158: 647-54. Medline:11159201
31. Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. Clinical and histological associations of cagA and vacA genotypes in helicobacter pylori gastritis. J Clin Pathol. 1998; 51: 55-61. Medline:9577374 doi:10.1136/jcp. 51.1.55
32. Graham DY, Genta RM, Graham DP, Crabtree Je. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of igG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol. 1996; 49: 829-32. Medline:8943750 doi:10.1136/jcp. 49.10.829
33. Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, et al. Atrophic gastritis and intestinal metaplasia in helicobacter pylori infection: the role of CagA status. Am J Gastroenterol. 1998; 93: 375-9. Medline:9517643 doi:10.1111/j.1572-0241.1998.00375.x (Pubitemid 29068340)
34. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. lab invest. 1995; 73: 760-70. Medline:8558837 (Pubitemid 26002335)
35. Audibert C, Janvier B, Grignon B, Salaun l, Burucoa C, Lecron JC, et al. Correlation between IL-8 induction, cagA status and vacA genotypes in 153 French Helicobacter pylori isolates. Res Microbiol. 2000; 151: 191-200. Medline:10865946 doi:10.1016/S0923-2508 (00) 00139-X
36. Perez-Perez GI, Peek RM Jr, Atherton JC, Blaser MJ, Cover TL. Detection of anti-VacA antibody responses in serum and gastric juice samples using type s1/m1 and s2/m2 helicobacter pylori VacA antigens. Clin diagn lab immunol. 1999; 6: 489-93. Medline:10391848
37. Ricci V, Ciacci C, Zarrilli R, Sommi P, Tummuru MK, Del Vecchio Blanco C, et al. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun. 1996; 64: 2829-33. Medline:8698518
38. Phadnis SH, Ilver D, Janzon l, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun. 1994; 62: 1557-65. Medline:8168917
39. Weel JF, van der Hulst RW, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J infect Dis. 1996; 173: 1171-5. Medline:8627069
40. Sokic-Milutinovic A, Wex T, Todorovic V, Milosavljevic T, Malfertheiner P. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro. Scand J Gastroenterol. 2004; 39: 222-6. Medline:15074390 doi:10.1080/00365520310008403 (Pubitemid 38388865)
41. Lofeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ. IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains. FeMS Immunol Med Microbiol. 2000; 28: 139-41. Medline:10799804 doi:10.1111/j.1574-695X.2000.tb01468.x
42. Graham DY, Yamaoka Y. Disease-specifc Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter. 2000; 5 Suppl 1: S3-9. Medline:10828748 doi:10.1046/j.1523-5378.2000.0050S1003.x